Rocket Lab's upcoming quarterly update comes at a key inflection point for the end-to-end space company. The business continues to scale rapidly, with second-quarter revenue of $234 million reflecting a 62% year-over-year increase and a new record high. At the same time, profitability remains elusive, as evidenced by a GAAP net loss of $49.3 million in Q2. Strategic moves are also in focus, including the roughly $3.6 billion agreement to acquire satellite operator Iridium, which would bring a 66-satellite constellation and recurring revenue streams, alongside ongoing heavy investment in the medium-lift Neutron rocket. In my view, how management addresses Neutron's schedule, margin trends from acquired businesses, and cash usage will influence sentiment ahead of the report. I also checked this using Tickeron's AI Screener to see how RKLB stacks up against peers in the sector.
For the third quarter of 2026, Rocket Lab has guided revenue to $250 million to $265 million and an adjusted EBITDA loss of $17 million to $23 million. The company projects GAAP gross margin of 29%–31% and non-GAAP gross margin of 35%–37%, reflecting a sequential decline tied to shifts in space systems mix and integration costs from recent acquisitions. These are company-provided figures rather than analyst consensus, so actual results will be measured against both. For context, Q2 2026 revenue came in at $234.07 million (up 62% year over year) and modestly exceeded expectations, though the GAAP loss of $0.08 per share fell short of the roughly $0.06 consensus loss. Backlog reached $2.36 billion, with about 45.5% anticipated to convert to revenue within 12 months. Shares of RKLB have historically shown sharp reactions to Neutron-related updates and guidance, highlighting the value of forward commentary alongside the headline numbers.
Sentiment leading into the report appears mixed. Revenue growth and the record backlog have generated enthusiasm, yet the stock remains sensitive to developments around the Neutron first-flight timeline and the costs of scaling operations. In Q2, revenue beat estimates while the per-share loss missed, and Q3 margin guidance points lower, keeping attention on the path to profitability beyond top-line expansion. Commentary on Neutron testing, any schedule adjustments, and progress on the pending Iridium transaction stand out as likely drivers of post-report movement. Elevated negative free cash flow and acquisition-related integration costs continue to be key risk factors under consideration.
Looking beyond the Q3 numbers, attention will center on Neutron, the medium-lift rocket that underpins Rocket Lab's longer-term growth prospects and competitiveness for larger government and commercial contracts. Management has targeted a pad arrival in Q4 2026, though schedule risk has persisted, and any fresh details on the first-flight timeline will draw scrutiny. The pending Iridium acquisition represents another focal point. If completed, it would position Rocket Lab as the operator of a 66-satellite constellation with recurring revenue and roughly $870 million in annual revenue, though closing is not expected until mid-2027 and involves integration and financing considerations. Margin trends in the space systems segment also warrant monitoring, given pressure from lower-margin satellite platforms and acquisition costs. Cash consumption for Neutron development and production ramp-up is likely to stay elevated, making free cash flow and liquidity metrics important indicators. Backlog conversion and new contract announcements will further signal whether the company can maintain its revenue momentum while advancing toward profitability.
From what I see, tools like Tickeron's AI Screener help cut through the noise when analyzing names in fast-moving sectors. It allows filtering by technical patterns, fundamentals, and industry signals to surface comparable ideas and momentum trends efficiently. I’ve found it useful for cross-checking RKLB against aerospace and defense peers without spending hours on manual reviews.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
RKLB saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 79 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RKLB's RSI Oscillator exited the oversold zone, 28 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 265 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 194 of 239 cases where RKLB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for RKLB turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 33 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
RKLB moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RKLB crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.717) is normal, around the industry mean (5.050). RKLB's P/E Ratio (-196.556) is considerably lower than the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.367).
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RKLB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense